← Open Payments lookup

ISAAC KUFFOUR: Open Payments

NPI 1568233229 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$551 in 22 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $551

Food & beverage: $551
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc8$218
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$89
E.R. Squibb & Sons, L.L.C.3$82
Otsuka America Pharmaceutical, Inc.3$62
Neurocrine BioSciences, Inc.2$40
Teva Pharmaceuticals USA, Inc.1$38
Alkermes, Inc.1$21

Products named: INVEGA SUSTENNA, CAPLYTA, COBENFY, ABILIFY ASIMTUFII, INGREZZA, UZEDY, ARISTADA.

Industry payments across CA — which companies pay providers there.